Publication Name	World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID	101753
Country	India

Received	2024-09-26 07:26
Peer-Review Started	2024-09-26 07:26
To Make the First Decision
Return for Revision	2024-11-25 07:05
Revised	2024-12-05 05:23
Second Decision	2025-01-02 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-01-02 10:57
Articles in Press	2025-01-02 10:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-02-27 03:22
Publish the Manuscript Online	2025-03-03 07:31

ISSN	2150-5349 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Rebamipide in gastric mucosal protection and healing: An Asian perspective
Manuscript Source	Unsolicited Manuscript
All Author List	Manish Kak
Funding Agency and Grant Number	Funding Agency Grant Number Dr Reddy's Laboratories, Hyderabad, India
Corresponding Author	Manish Kak, MD, Department of Gastroenterology, Manipal Hospital, NH-24 Hapur Road, Near Landcraft Golflinks, Pandav Nagar, Ghaziabad 201002, Uttar Pradesh, India. manishkak@yahoo.com
Key Words	Rebamipide; Peptic ulcer; Gastroesophageal reflux disease; Mucosal protection; Treatment
Core Tip	This review highlights rebamipide’s superior safety and efficacy in treating gastric ulcers and mucosal disorders, making it a strong candidate for inclusion in global treatment guidelines. An extensive literature review reveals its multifaceted mechanism of action, including prostaglandin synthesis, free radical scavenging, and mucin production enhancement, leading to enhanced mucosal protection and ulcer healing. Rebamipide often surpasses other common treatments like pantoprazole and esomeprazole due to its low adverse event rate and mild side effects. Its broad application extends to ophthalmology, oncology, and bone regeneration, further underscoring its therapeutic versatility.
Publish Date	2025-03-03 07:31
Citation	<p>Kak M. Rebamipide in gastric mucosal protection and healing: An Asian perspective. <i>World J Gastrointest Pharmacol Ther</i> 2025; 16(1): 101753</p>
URL	https://www.wjgnet.com/2150-5349/full/v16/i1/101753.htm
DOI	https://dx.doi.org/10.4292/wjgpt.v16.i1.101753

Full Article (PDF)	WJGPT-16-101753-with-cover.pdf
Manuscript File	101753_Auto_Edited_025915.docx
Answering Reviewers	101753-answering-reviewers.pdf
Audio Core Tip	101753-audio.mp3
Conflict-of-Interest Disclosure Form	101753-conflict-of-interest-statement.pdf
Copyright License Agreement	101753-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	101753-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	101753-non-native-speakers.pdf
Peer-review Report	101753-peer-reviews.pdf
Scientific Misconduct Check	101753-scientific-misconduct-check.png
Scientific Editor Work List	101753-scientific-editor-work-list.pdf
CrossCheck Report	101753-crosscheck-report.pdf